The Role of Metastasis - Directed Therapy for OMD Prostate Cancer
Join us on Thursday, December 10, 2026 from 12:00pm - 1:00pm ET
Format: Interactive Discussion
The program will feature discussions on key concepts using case studies.
Dr. Piet Ost
Radiation Oncologist at Iridium Network, and associate professor at Ghent University, Belgium.
Dr. Ost became a medical doctor at Ghent University in 2006, received his PhD in medical sciences in 2011, did specialized training in radiation oncology and became a board certified Radiation Oncologist in 2012. His key research areas include prostate cancer (oligometastatic and metastatic disease), stereotactic body radiotherapy (SBRT), metastasis-directed therapy, immunotherapy combined with radiotherapy, and novel diagnostic imaging and molecular profiling.
Dr. Scott Tyldesley
Clinical Professor in Radiation Oncology at UBC, and previous Program Head Radiation Therapy at BC Cancer Agency 2016 to 2022.
Dr. Tyldesley completed his MD at UBC in 1993, residency in Radiation Oncology at the BCCA in 1998, and Masters in Public Administration at Queen’s University as a disciple of Professor William Mackillop. He has been a staff Radiation Oncologist at the BC Cancer Agency Vancouver Centre since 2000. His areas of expertise include genitourinary radiation oncology, health policy, health services research, operations research, and needs assessment. He is a former Michael Smith Foundation Scholar in Health Services Research and a CARO Gold Medalist, with over 200 publications related to oncology.
R E G I S T E R